Databases for Pharmacoepidemiological Research - Practical RWE Guide

In this review of Databases for Pharmacoepidemiological Research readers will find a focused, practical guide to how real-world data are used in pharmacoepidemiology. The book is aimed at researchers, epidemiologists and regulatory scientists who need a clear treatment of electronic healthcare databases and their value for post-approval drug and vaccine studies. Its single biggest reason to buy is the detailed, comparative discussion of database strengths and limitations that helps readers judge suitability of data sources for real-world evidence studies.

Key Features

• Comprehensive coverage: Explains the role of electronic healthcare databases in pharmacoepidemiology and how they support analyses of drug and vaccine utilization after approval.
• Comparative perspective: Highlights the strengths and limitations of different databases so readers can assess suitability for specific study questions.
• Focus on rare outcomes: Describes how long-term, large databases are especially useful for identifying rare risks and rare exposures.
• Regulatory relevance: Connects real-world evidence to clinical and regulatory decision-making to clarify practical implications for post-marketing research.
• Methodological insight: Offers context on how real-world data enable investigations of comparative effectiveness and safety in routine care settings.

Who It's For

This book is best for pharmacoepidemiologists, biostatisticians and public health researchers who work with electronic healthcare records and need to understand data source selection, bias considerations and the types of inferences that real-world evidence supports. Graduate students in epidemiology seeking a data-centered view of post-approval research will also find it useful.

Practitioners who require hands-on programming examples or a textbook of statistical techniques may need supplementary resources, since the emphasis here is on database roles and comparative strengths rather than step-by-step coding or exhaustive methodological derivations.

Pros & Cons

Pros

• Clear explanation of why electronic healthcare databases are central to post-approval drug and vaccine studies.
• Helpful comparison of database strengths and limitations to guide study design choices.
• Emphasizes the value of large, long-term datasets for detecting rare risks and exposures.

Cons

• Not a hands-on methods manual, so readers seeking code or detailed statistical formulas will need additional texts.

Specifications

Title	Databases for Pharmacoepidemiological Research
Series	Springer Series on Epidemiology and Public Health
Authors	Miriam Sturkenboom, Tania Schink
Primary focus	Role of real-world data in pharmacoepidemiology
Key applications	Drug and vaccine utilization, comparative effectiveness and safety
Strength emphasized	Identification of rare risks and rare exposures over long periods

Our Verdict

Databases for Pharmacoepidemiological Research is a valuable, well-focused reference for researchers and regulators who need to understand how electronic healthcare databases contribute to real-world evidence. It is good value for anyone choosing data sources for post-approval safety or utilization studies, though those needing practical coding examples should pair it with methodological handbooks.

Frequently Asked Questions

Does this book explain different types of healthcare databases?
Yes. It highlights the strengths and limitations of respective electronic healthcare databases relevant to pharmacoepidemiological research.

Is it suitable for clinicians without research experience?
Clinicians can gain a conceptual understanding, but readers without research background may find some sections more technical and best paired with introductory epidemiology texts.

Will it help with regulatory submissions?
The book discusses the regulatory relevance of real-world evidence, offering context useful for researchers preparing post-marketing safety and effectiveness studies.